ESPE Abstracts (2018) 89 P-P2-192

Hyperinsulinemic Hypoglycemia in Congenital Disorder of Glycosylation Type-1a (CDG-1a)

Dogus Vurallia, Yilmaz Yildizb, H. Serap Sivrib & Ayfer Alikasifoglua


aHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey; bHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Metabolism and Nutrition, Ankara, Turkey


Introduction: Congenital disorder of glycosylation type-1a is a multi-system disease involving neurological, gastrointestinal, ophthalmologic, cardiac or endocrine systems. In addition to hypothyroidism and hypergonadotropic hypogonadism, rare occurrences of hyperinsulinemic hypoglycemia in CDG patients have been reported. In the present report, we describe a patient diagnosed with CDG type-1a accompanied by hyperinsulinemic hypoglycemia, and whose responsive to diazoxide.

Case: The female patient was referred to our hospital at the age of 8 months with the complaint of failure to thrive. She was born at term as the first child of healthy non-consanguineous parents. Her weight was 6 kg (<3p), height was 63 cm (3p). She had strabismus, axial hypotonia, a hepatomegaly of 3 cm below the margin, inverted nipples and an abnormal distribution of subcutaneous fat. Routine investigations revealed hypoalbuminaemia, hypertransaminasemia, minimally raised prothrombin time. The patient’s serum glucose was 36 mg/dl, and the concurrently measured insulin:3.1 μIU/ml, c-peptide:1 ng/ml, cortisol:6.19 μg/dl, ACTH:25.8 pg/ml, GH:8.01 ng/ml, lactic acid:14 mg/dl(N:4.5-19.8), ammonia:33 μg/dl(N:20-120), tandem mass spectrometry, plasma and urine amino acid profiles, urine organic acid analyses were normal. Low dose ACTH stimulation and thyroid function tests were normal. As the patient was hypoglycemic, IV glucose infusion was given at a rate of 8 mg/kg/min. Hyperinsulinism was considered, since the levels of insulin and c-peptide were elevated while the patient was hypoglycemic, and exaggerated glucose response was seen in the glucagon test, and the patient was started on diazoxide. The patient experienced no new episodes of hypoglycemia after treatment. Transferrin isoform electrophoresis, requested following a preliminary diagnosis of CDG, based on the appearance of bilateral inverted nipples and abnormal distribution of subcutaneous fat, was abnormal with type 1 pattern. A homozygous mutation was detected in a PMM2 gene analysis (c.385G>A). Cranial MRI showed cerebellar atrophy and diffuse volume loss in the brainstem, echocardiography demonstrated pericardial effusion and increased echogenicity in the myocardium, and the lipid profile showed hypertriglyceridemia and low HDL levels, which were consistent with the CDG.

Conclusion: Hyperinsulinemic hypoglycemia accompanying CDG type-1a has been reported in very few cases, and its etiology is still to be clarified. Based on a previously suggested hypothesis, an abnormal glycosylation of the KATP channels may result in hyperinsulinism, and so patients respond well to diazoxide, as an agent with proven activity in KATP channels.

Article tools

My recent searches

No recent searches.